Literature DB >> 28166534

Prognostic Factors Associated with Preoperative Clinicophysiological Outcomes of Distal Cholangiocarcinoma.

Shuji Suzuki1, Hideki Kajiyama, Mitsugi Shimoda, Jiro Shimazaki, Nobusada Koike, Nobuhiko Harada.   

Abstract

BACKGROUND/AIMS: Although biliary tract cancer is generally associated with a high mortality rate, patients with distal cholangiocarcinoma have better prognoses, compared to those with periampullary cancer. This study aimed to determine the preoperative clinicophysiological factors predictive of survival and recurrence in patients with distal cholangiocarcinoma.
METHODS: Forty-five patients (34 men) with distal cholangiocarcinoma who underwent pancreaticoduodenectomy between 2005 and 2013 were examined retrospectively at our center and associated hospitals. Clinicophysiological parameters included predictors of overall survival (OS). Kaplan-Meier survival curves were generated and compared using log-rank tests, and Cox proportional hazard multivariate analyses were performed.
RESULTS: The mean patient age was 68.8 years (range 54-81 years). Patients had a median OS duration of 43 months, and 1-, 3-, and 5-year OS rates of 91.1, 61.1, and 40.4%, respectively. Univariate analyses indicated that the body mass index, C-reactive protein (CRP) level, and carcinoembryonic antigen level were independent prognostic factors for OS; however, only the CRP level remained an independent prognostic factor in a multivariate analysis.
CONCLUSIONS: A CRP level <0.3 mg/dL was predictive of a better outcome among patients with distal cholangiocarcinoma.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  C-reactive protein; Clinicophysiological factor; Distal cholangiocarcinoma; Overall survival; Pancreaticoduodenectomy

Mesh:

Substances:

Year:  2017        PMID: 28166534     DOI: 10.1159/000456082

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  3 in total

1.  Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with 125I seeds intracavitary irradiation.

Authors:  X Hu; Q Pang; H Liu; Z Qian; H Jin; L Zhou; Y Wang; Z Man; Z Li; S Yang
Journal:  Clin Transl Oncol       Date:  2018-10-27       Impact factor: 3.405

2.  Albumin-Bilirubin Grade as a Novel Predictor of Survival in Advanced Extrahepatic Cholangiocarcinoma.

Authors:  Yong Wang; Qing Pang; Hao Jin; Lei Zhou; Xiaosi Hu; Zhen Qian; Zhongran Man; Song Yang; Huichun Liu
Journal:  Gastroenterol Res Pract       Date:  2018-12-02       Impact factor: 2.260

3.  Influence of non-jaundice stage at diagnosis on clinicopathological features and long-term survival of patients with periampullary carcinomas.

Authors:  Xiaoqian Peng; Xiaoxiao Jiao; Ping Zhao; Rongtao Zhu; Yuling Sun; Lin Zhou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.